143 related articles for article (PubMed ID: 35478268)
1. Outcome of females with Alport syndrome.
Koyun M; Aksoy GK; Çomak E; Akman S
Pediatr Nephrol; 2022 Aug; 37(8):1937. PubMed ID: 35478268
[No Abstract] [Full Text] [Related]
2. Genetic testing and glomerular hematuria-A nephrologist's perspective.
Kashtan CE
Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):399-403. PubMed ID: 35775584
[TBL] [Abstract][Full Text] [Related]
3. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
[TBL] [Abstract][Full Text] [Related]
4. Novel COL4A3 gene mutations in a consanguineous family with autosomal recessive Alport syndrome.
Sirisena ND; Thalgahagoda S; Abeyagunawardena A; Neumann M; Schmudlach HO; Jayasekara RW; Dissanayake VH
Nephrology (Carlton); 2015 Aug; 20(8):580. PubMed ID: 26194984
[No Abstract] [Full Text] [Related]
5. Prevalence Estimates of Predicted Pathogenic
Gibson J; Fieldhouse R; Chan MMY; Sadeghi-Alavijeh O; Burnett L; Izzi V; Persikov AV; Gale DP; Storey H; Savige J;
J Am Soc Nephrol; 2021 Sep; 32(9):2273-2290. PubMed ID: 34400539
[TBL] [Abstract][Full Text] [Related]
6. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
[TBL] [Abstract][Full Text] [Related]
7. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
[TBL] [Abstract][Full Text] [Related]
8. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group.
Kashtan CE; Ding J; Garosi G; Heidet L; Massella L; Nakanishi K; Nozu K; Renieri A; Rheault M; Wang F; Gross O
Kidney Int; 2018 May; 93(5):1045-1051. PubMed ID: 29551517
[TBL] [Abstract][Full Text] [Related]
9. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
Slajpah M; Gorinsek B; Berginc G; Vizjak A; Ferluga D; Hvala A; Meglic A; Jaksa I; Furlan P; Gregoric A; Kaplan-Pavlovcic S; Ravnik-Glavac M; Glavac D
Kidney Int; 2007 Jun; 71(12):1287-95. PubMed ID: 17396119
[TBL] [Abstract][Full Text] [Related]
10. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
[TBL] [Abstract][Full Text] [Related]
11. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
12. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
[TBL] [Abstract][Full Text] [Related]
13. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility gene card for: Alport syndrome - update 2014.
Hertz JM; Thomassen M; Storey H; Flinter F
Eur J Hum Genet; 2015 Sep; 23(9):. PubMed ID: 25388007
[No Abstract] [Full Text] [Related]
15. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
16. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
17. Familial hematurias: what we know and what we don't.
Kashtan CE
Pediatr Nephrol; 2005 Aug; 20(8):1027-35. PubMed ID: 15856317
[TBL] [Abstract][Full Text] [Related]
18. A founder mutation in COL4A3 causes autosomal recessive Alport syndrome in the Ashkenazi Jewish population.
Webb BD; Brandt T; Liu L; Jalas C; Liao J; Fedick A; Linderman MD; Diaz GA; Kornreich R; Trachtman H; Mehta L; Edelmann L
Clin Genet; 2014 Aug; 86(2):155-60. PubMed ID: 23927549
[TBL] [Abstract][Full Text] [Related]
19. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
[TBL] [Abstract][Full Text] [Related]
20. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
